Anti-Bacterial Flashcards
Cell wall inhibitors
B-lactams
B-lactams
Penicillins Cephalosporins Monobactams Carbapenams Glycopeptides Polypeptides Phosphoenolpyruvates
MOA Penicillins
“CILLIN”
bind/inhibit PBP = no peptidoglycan/cell wall synthesis
AE Penicillins
Hypersensitivity
Severe - cross-reaction to other B-lactams
Resistant to B-lactamase
Very-narrow spectrum - Methicillin, Nafcillin, Oxacillin
Combination w/B-lactamase inhibitors
Amoxicillin + Clavulanic Acid = Augmentin
RES Penicillins
Expression of B-lactamase
Alteration in PBP binding
Alteration in porin function
MOA Cephalosporin
Prefix “CEF”
same MOA as Penicillin
More resistance to B-lactamase
Broadness of spectrum increases with generation
4th gen - B-lactamase resistant; enter CNS
4th Gen Cephalosporin
Cefepime
RES Cephalosporin
Expression of B-lactamase
Alteration in PBP binding
Alteration in porin formation
MOA Monobactam
bind PPs
B-lactamase resistant; limited spectrum
Enter CSF - treat pneumonia, meninigitis, sepsis
One Drug - Aztreonam
AE Aztreonam
Hypersensitivity
AE Cephalosporin
Hypersensitivity
MOA Carbapenams
“PENEM”
bind PBP - used for empirical and life-threatening
B-lactamase resistant; Cambamenemase susceptible
AE Carbapenam
GI - N/V/D
Carbapenam inactivated in kidney
Imipenem - co-administer with Cilastatin
MOA Glycopeptides
Vancomycin
Prevent peptidoglycan elongation - D-ala-D-ala
AE Vancomycin
skin irritation - flushing, red neck, red man syndrome
MOA Polypeptide
Bacitracin
block amino acid/nucleic acid incorporation into cell wall
Broad spectrum - restricted to topical